Home / Uncategorized / FDA panel backs weight loss drug, despite risks

FDA panel backs weight loss drug, despite risks

The FDA previously rejected the drug, Qnexa, because component drugs were tied to heart problems and birth defects

See the article here:
FDA panel backs weight loss drug, despite risks

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top